Infralow neurofeedback in the treatment of substance use disorders: a randomized controlled trial.

ABSTRACT:

Background

Infralow neurofeedback (ILF-NF) was recently developed as a subtype of traditional, frequency-based neurofeedback that targets cerebral rhythmic activity below 0.5 Hz and improves brain self-regulation. The efficacy of ILF-NF in the treatment of substance use disorder has not yet been evaluated, but clinical evidence suggests that it may prevent relapse by improving functioning in various life domains. The current study aimed to fill this research gap and extend empirical evidence related to this issue.

Methods

Ninety-three patients with substance use disorders at an outpatient unit in Norway were randomized to receive 20 sessions (30 minutes each) of ILF-NF training combined with treatment as usual (TAU), or TAU alone. The primary outcome was quality of life post

SUBMITTER: Gabrielsen KB 

PROVIDER: S-EPMC9343117 | biostudies-literature | 2022 May-Jun

REPOSITORIES: biostudies-literature